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ImprovedMicro-ScaleHighPressure Llquid-Chromatographlc Assay of Gentamicin in Plasma
To the Editor:
A simple high-pressure liquid-chromatographic (HPLC) method for the determination of gentamicin in plasma or serum was reported (1) . The method involves acetonitrile deproteinization, methylene chloride extraction, dansylation with dansyl chloride, extraction of dansyl derivatives with ethyl acetate after addition of carbonate buffer, chromatography of an aliquot of the ethyl acetate extract on a reversedphase column, and quantitation with a fluorescence detector. We wish to report several improvements and precautions in the use of the assay, based on experience during the last year.
In our earlier assay, with use of one reversed-phase column (,s-Bondapak C18; Waters Associates, Milford, Mass. 01757), the composition of mobile phase is critical for the proper resolution of dansylated products, and a mixture of acetonitrile/water (95/5 by vol) was chosen for routine use (1) . In switching to other new columns this composition of mobile phase was often found to be unsatisfactory and a new composition of mobile phase ranging from 87 to 94% acetonitrile had to be selected for each column. it is also strongly recommended that a new column be exclusively used for gentamicin and other aminoglycosides that require the same mobile phase (2) . Brief use of some acidic mobile phases (e.g., pH 2-4) appears to have irreversibly changed certain column characteristics, making the column ususable for gentamicin assays. It must be noted, however, that such a treatment may not affect the column performance for other drugs.
We have used two sources of dansyl chloride in our earlier study, one from Pierce Chemical Co., Rockford, Ill. 61105, and one from Sigma Chemical Co., St. Louis, Mo. 63178. The former was much less soluble in acetonitrile than the latter, and yielded erratic results. The source of dansyl chloride reported previously (1) should be Sigma Chemical Co., not Pierce Chemical Co. It is of interest that, based on our preliminary study using a differential thermal calorimeter (Model 990; Du Pont, Wilmington, DeL 19898), these two sources of dansyl chloride showed essentially the same melting point. The optimal amount of dansyl chloride used for each reaction was originally reported to be 2.5mg (1). After several months of experiments using this amount (from the same reagent bottle), spurious results sometimes occurred. This was avoided by increasing dansyl chloride to 4 mg (in 0.3 ml of acetonitrile) for each reaction (2). We find that 50 or 100 il of plasma or serum is also adequate for routine drug monitoring and pharmacokinetic studies, In our earlier study the lowest plasma concentration tested using 200 il of sample was 1.2 mg/liter. Using 50 or 100 l of plasma we could also accurately quantitate gentamicin down to 0.145 mg/liter. Standard curves based on the second gentamicin peak (3) for concentrations below 1.2 mg/liter are shown in Figure 1 . The therapeutic range for gentamicin is between 2 and 8 mg/ liter.
The chromatographic peak height is often assumed to increase linearly with the volume injected, especially when the volume is relatively small (e.g., <10 il). This is not the case for our gentamicin assay. There is a less than proportional increase in peak height with an increase of volume injected from the same solution. Figure 2 shows typical results from duplicate studies. A volume of 5 il for injection is adequate for most studies; sometimes a 2-gil injection is superior to 5 l or more in terms of sharpness of peak and degree of interference by other peaks.
The improvements and precautions described here should also be applicable to the assay for netilmicin (2) . With a proper dilution of samples, the method can also be used to measure gentainicin and netilmicin in urine. 
CephaiosporlnAntibiotic interferencewith Analysisfor Theophylilneby High-Performance LiquidChromatography
To the Editor:
We read with interest the Letter about cephalosporin interference in theophylline analysis (1). We have evaluated the effect of cephalosporins in use in our hospital on this theophylline method,
We analyzed for theophylline in serum by the following procedure: Serum was diluted with an equal volume of 100% acetonitriie containing the internal standard, $-hydroxyethyi theophylline. We used the procedure of Orcutt et al. (2) and carried out the analysison a Waters Associates chromatograph with a Bondapack C18column. All chromatographic procedures were exactly as described by Orcutt et al. Figure 1 shows our analysis oftheophylline and the internal standard. Figure 2 shows the effect of addition of cephalothin (Cefadyl;
Bristol Labora- tories). Cephalothin interfered with the internal standard peak; however, this interference would be recognized by most operators.
None of the other cephalosporins in use in our hospital caused any direct interference with this theophylline analysis. Table 1 
